Skip to content

A trial comparing two trifocal toric intraocular lens

A prospective, multicenter clinical study comparing outcomes of two trifocal toric intraocular lens

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040590
Enrollment
84
Registered
2022-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

Intervention1: OPTIFLEX TRIO (Hydrophobic Aspheric Foldable IOL): This lenses are designed to provide all near, distance and intermediate vision and thereby reduce spectacle dependency. It is manufact

Sponsors

Biotech Healthcare Holdings GmbH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age of patient >21 years 2.Patient diagnosed with cataract 3.Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5D as per corneal topography or keratometry 4.Calculated IOL Power is within the range of the investigational IOLs 5.Patient willing to sing informed consent form 6.Clear intraocular media other than cataract 7.Female participants of child bearing potential must be willing to ensure that they use effective contraception during the study

Exclusion criteria

Exclusion criteria: 1.Previous intraocular or corneal surgery 2.Traumatic Cataract. 3.Pregnancy (as stated by patient) or lactation 4.Concurrent participation in another drug or device investigation 5.Irregular Astigmatism 6.Patient receiving chlorquine treatment 7.Subjects with any systemic disease that could increase operative risk or confound the outcome 8.Active ocular disease in the operative eye other than cataract 9.Vulnerable subjects 10.Corneal Astigmatism >4.5D

Design outcomes

Primary

MeasureTime frame
To compare the distance-corrected intermediate visual acuity between the two trifocal toric intraocular lensesTimepoint: ➢ Post-operative 1 Day ➢ Post-operative 1 Week �± 2 Days ➢ Post-operative 1 Month �± 7 Days ➢ Post-operative 3 Months �± 7 Days ➢ Post-operative 6 Months �± 14 Days ➢ Post-operative 12 Months �± 30 Days

Secondary

MeasureTime frame
To assess and compare the safety of two trifocal toric intraocular lensesTimepoint: ➢ Post-operative 1 Day ➢ Post-operative 1 Week �± 2 Days ➢ Post-operative 1 Month �± 7 Days ➢ Post-operative 3 Months �± 7 Days ➢ Post-operative 6 Months �± 14 Days ➢ Post-operative 12 Months �± 30 Days

Countries

Germany, India

Contacts

Public ContactMr Devendrapalsingh Khalsa

BIOTECH VISION CARE PVT. LTD

devendra@biotechhealthcare.com9376178887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026